KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours-Reference-Cited by-同舟云学术

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

Published:2006-05 Issue:8 Volume:42 Page:1093-1103
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Debiec-Rychter Maria,Sciot Raf,Le Cesne Axel,Schlemmer Marcus,Hohenberger Peter,van Oosterom Allan T.,Blay Jean-Yves,Leyvraz Serge,Stul Michel,Casali Paolo G.,Zalcberg John,Verweij Jaap,Van Glabbeke Martine,Hagemeijer Anne,Judson Ian

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumours;Hirota;Science,1998

2. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumours and do not occur in leiomyomas or leiomyosarcomas;Lasota;Am J Pathol,1999

3. KIT activation is a ubiquitous feature of gastrointestinal stromal tumours;Rubin;Cancer Res,2001

4. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumours;Lux;Am J Pathol,2000

5. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat Med,1996

Cited by 760 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The INSIGHT study: a randomized, Phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations;Future Oncology;2024-09-04

2. Molecular testing of gastrointestinal tumours;Diagnostic Histopathology;2024-09

3. Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research;Global Medical Genetics;2024-08-22

4. Molecular Profiling of KIT/PDGFRA-Mutant and Wild-Type Gastrointestinal Stromal Tumors (GISTs) with Clinicopathological Correlation: An 18-Year Experience at a Tertiary Center in Kuwait;Cancers;2024-08-21

5. Therapeutic advances of targeting receptor tyrosine kinases in cancer;Signal Transduction and Targeted Therapy;2024-08-14